“Antiproliferative effects of 13α/β-steroids on triple-negative MDA-MB-231 breast cancer cells: unraveling intracellular signaling without ERα”, Braz. J. Pharm. Sci., vol. 59, p. e22540, May 2023, doi: 10.1590/s2175-97902023e22540.